Atlas Trials

Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast Cancer

Clinical trial NCT03979911 · UNKNOWN

Trial details

NCT number
NCT03979911
Sponsor
University Hospital, Brest
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast NeoplasmsHER-2 Gene Amplification
Start date
2019-01-22
Primary completion
2019-07-22
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.